Model-Informed Drug Discovery and Development in Pulmonary Delivery: Biopharmaceutical Pharmacometric Modeling for Formulation Evaluation of Pulmonary Suspensions

[Image: see text] For respiratory conditions, targeted drug delivery to the lungs could produce higher local concentrations with reduced risk of adverse events compared to systemic administration. Despite the increasing interest in pulmonary delivery, the pharmacokinetics (PK) of drugs following pul...

Descripción completa

Detalles Bibliográficos
Autores principales: Sou, Tomás, Soukarieh, Fadi, Williams, Paul, Stocks, Michael J., Cámara, Miguel, Bergström, Christel A. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557213/
https://www.ncbi.nlm.nih.gov/pubmed/33073099
http://dx.doi.org/10.1021/acsomega.0c03004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557213/
https://www.ncbi.nlm.nih.gov/pubmed/33073099
http://dx.doi.org/10.1021/acsomega.0c03004

Ejemplares similares